Hated stocks and biotech are the best bets right now, according to the author of today’s article. Focusing in on the latter, biotech, he offers two recommendations for upside: an early-stage med-tech company that insiders have been buying – and whose shares he expects to double over the next year – and a biotech ETF comprised of small-cap names that have more room to run. For more, CLICK HERE.
2 Recommendations For Biotech Upside
- by Alex Clarke
Tags:Biotech StocksBiotech UpsideBuyingDoubling InvestmentsETFsInsidersMed-Tech CompanySmall-CapsStock Market